Dmitry A. Lega
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Dmitry A. Lega has a total of 69 co-authors. Here are the top co-authors by number of shared publications:
- Dmitriy M. Volochnyuk
Taras Shevchenko National University of Kyiv
7 shared publications - Leonid A. Shemchuk
National University of Pharmacy
7 shared publications - Sergey V. Ryabukhin
Taras Shevchenko National University of Kyiv, 60 Volodymyrska str., Kyiv, Ukraine, 01033
7 shared publications - Andrzej Gzella
Department of Organic Chemistry, Poznan University of Medical Sciences, Grunwaldzka 6, 60-780 Poznan, Poland
4 shared publications - Alexander B. Rozhenko
Taras Shevchenko National University of Kyiv
3 shared publications - Eugeniy Ostapchuk
Enamine (Ukraine)
3 shared publications
Latest Publications
- Open Access
- 5 November 2025
- Published by American Chemical Society (ACS) in ChemRxiv
Dialkylphosphine Oxides: Synthetic Challenges and Medicinal Chemistry Application
For decades, organophosphorus derivatives of the phosphine oxide class were dismissed as unwanted by-products of classical transformations and largely ignored by applied chemistry. The paradigm shifted in 2017 with the FDA approval of brigatinib, the first anticancer drug containing a phosphine oxide moiety. The key to its success was the dimethylphosphinoyl group, which conferred high affinity to the biological target. This breakthrough renewed interest in phosphinoyl fragments, stimulating exploration of their chemical space and physicochemical properties. Reviews to date have focused on synthetic approaches to di(het)arylphosphine oxides, while no comparable systematization exists for dialkyl analogues. The present survey addresses this gap by summarizing advances in the synthesis of dialkylphosphine oxides and their emerging role in drug design, covering developments from the 1950s to the present.
- 5 November 2025
- Published by American Chemical Society (ACS) in ChemRxiv
Open AccessDialkylphosphine Oxides: Synthetic Challenges and Medicinal Chemistry Application
For decades, organophosphorus derivatives of the phosphine oxide class were dismissed as unwanted by-products of classical transformations and largely ignored by applied chemistry. The paradigm shifted in 2017 with the FDA approval of brigatinib, the first anticancer drug containing a phosphine oxide moiety. The key to its success was the dimethylphosphinoyl group, which conferred high affinity to the biological target. This breakthrough renewed interest in phosphinoyl fragments, stimulating exploration of their chemical space and physicochemical properties. Reviews to date have focused on synthetic approaches to di(het)arylphosphine oxides, while no comparable systematization exists for dialkyl analogues. The present survey addresses this gap by summarizing advances in the synthesis of dialkylphosphine oxides and their emerging role in drug design, covering developments from the 1950s to the present.
- 1 April 2024
- Published by Springer Nature in Chemistry of Heterocyclic Compounds
- Vol. 60 (3-4) , 118-120
Recent advances in the chemistry of pyrrolidine-2,3-diones (microreview)
- 1 April 2024
- Published by Springer Nature in Chemistry of Heterocyclic Compounds
- Vol. 60 (3-4) , 118-120
Recent advances in the chemistry of pyrrolidine-2,3-diones (microreview)
- Open Access
- 8 March 2024
- Published by American Chemical Society (ACS) in ChemRxiv
PRACTICAL MULTIGRAM APPROACH TO CONFORMATIONALLY CONSTRAINED PROLINE-BASED BUILDING BLOCKS WITH GAMMA-SPIRO CONJUNCTION
Unusual amino acids have arisen as an indispensable instrument at the disposal of modern medicinal chemistry. While extensively exploited as building blocks in the search for new pharmaceuticals, their application goes far beyond and they are currently involved in the exploration of the structure and conformational mobility of peptides, modification and amplification of peptidomimetics’ activity, and others. Herein, we communicate an effective synthetic approach to non-planar, conformationally restricted, sp3-enriched spirocyclic -prolines. The protocol employs readily available nitrile starting materials and conventional experimental procedures. The synthetic sequence is concise and includes three principal stages (one of them is a 4-step through process). The reactions proceed on a multigram scale affording the target prolines in overall good yields. The building blocks synthesized in the study are expected to have practical uses in the field of medicinal chemistry.
- 8 March 2024
- Published by American Chemical Society (ACS) in ChemRxiv
Open AccessPRACTICAL MULTIGRAM APPROACH TO CONFORMATIONALLY CONSTRAINED PROLINE-BASED BUILDING BLOCKS WITH GAMMA-SPIRO CONJUNCTION
Unusual amino acids have arisen as an indispensable instrument at the disposal of modern medicinal chemistry. While extensively exploited as building blocks in the search for new pharmaceuticals, their application goes far beyond and they are currently involved in the exploration of the structure and conformational mobility of peptides, modification and amplification of peptidomimetics’ activity, and others. Herein, we communicate an effective synthetic approach to non-planar, conformationally restricted, sp3-enriched spirocyclic -prolines. The protocol employs readily available nitrile starting materials and conventional experimental procedures. The synthetic sequence is concise and includes three principal stages (one of them is a 4-step through process). The reactions proceed on a multigram scale affording the target prolines in overall good yields. The building blocks synthesized in the study are expected to have practical uses in the field of medicinal chemistry.
- Open Access
- 6 February 2024
- Published by American Chemical Society (ACS) in ChemRxiv
EFFICIENT MULTIGRAM SYNTHESIS OF 3,3-SPIRO-α-PROLINE CONTAINING CHIMERAS
A series of novel spirocyclic α-proline building blocks for drug discovery with a spiro conjunction in position 3 of pyrrolidine was prepared by means of two convenient and practical synthetic approaches. Both alternative routes utilize simple and easily available starting materials – cyclic ketones and esters – and comprise 6- and 7-steps, respectively. The methodologies feature several advantages, including exploitation of simple organic chemistry transformations and suitability for preparation of multigram amounts of the target prolines. Approach to other valuable chemicals – spirocyclic pyroglutamic acids – is also discussed.
- 6 February 2024
- Published by American Chemical Society (ACS) in ChemRxiv
Open AccessEFFICIENT MULTIGRAM SYNTHESIS OF 3,3-SPIRO-α-PROLINE CONTAINING CHIMERAS
A series of novel spirocyclic α-proline building blocks for drug discovery with a spiro conjunction in position 3 of pyrrolidine was prepared by means of two convenient and practical synthetic approaches. Both alternative routes utilize simple and easily available starting materials – cyclic ketones and esters – and comprise 6- and 7-steps, respectively. The methodologies feature several advantages, including exploitation of simple organic chemistry transformations and suitability for preparation of multigram amounts of the target prolines. Approach to other valuable chemicals – spirocyclic pyroglutamic acids – is also discussed.
- Open Access
- 6 February 2024
- Published by American Chemical Society (ACS) in ChemRxiv
CONCISE AND PRACTICAL AVENUES TO 5,5-SPIRO-α-PROLINES
Scaffold hopping and three-dimensionality are one of dominating notions in contemporary drug discovery process. Following these concepts is a verified and generally robust avenue to improve the biological activity of a lead against a protein target, selectivity issues as well as ADMET properties. Unfortunately, the freedom of medicinal chemists to replace molecular fragments responsible for the properties is restricted due to unrevealed areas of chemical space existing for even simple building blocks. This paper contributes to the support of drug discovery workflow and describes concise and practical synthetic approaches toward multigram preparation of value-added conformationally constrained 5-spirocyclic α-prolines from readily accessible starting materials. Direct carboxylation of 2-spiropyrrolidines was found to be a novel and promising approach to achieve the purpose and is the most fruitful for substrates with no acidic centers within a part spiro linked to pyrrolidine core. The method allows for quick and one-step preparation of the target chemicals in good yields. For substrates inapplicable to the straightforward method, an alternative synthetic avenue was designed. This 4-steps protocol deals with common for laboratory practice transformations and is comparable in its efficiency with the carboxylation method. The paper concludes a series of our works on the elaboration of efficient methods for the construction of spiro proline frameworks.
- 6 February 2024
- Published by American Chemical Society (ACS) in ChemRxiv
Open AccessCONCISE AND PRACTICAL AVENUES TO 5,5-SPIRO-α-PROLINES
Scaffold hopping and three-dimensionality are one of dominating notions in contemporary drug discovery process. Following these concepts is a verified and generally robust avenue to improve the biological activity of a lead against a protein target, selectivity issues as well as ADMET properties. Unfortunately, the freedom of medicinal chemists to replace molecular fragments responsible for the properties is restricted due to unrevealed areas of chemical space existing for even simple building blocks. This paper contributes to the support of drug discovery workflow and describes concise and practical synthetic approaches toward multigram preparation of value-added conformationally constrained 5-spirocyclic α-prolines from readily accessible starting materials. Direct carboxylation of 2-spiropyrrolidines was found to be a novel and promising approach to achieve the purpose and is the most fruitful for substrates with no acidic centers within a part spiro linked to pyrrolidine core. The method allows for quick and one-step preparation of the target chemicals in good yields. For substrates inapplicable to the straightforward method, an alternative synthetic avenue was designed. This 4-steps protocol deals with common for laboratory practice transformations and is comparable in its efficiency with the carboxylation method. The paper concludes a series of our works on the elaboration of efficient methods for the construction of spiro proline frameworks.
- 19 August 2023
- Published by Springer Nature in Chemistry of Heterocyclic Compounds
- Vol. 59 (6-7) , 1-8
Sulfo-Biginelli reaction: an insight into interaction between sulfamides and enolizable ketones
- 19 August 2023
- Published by Springer Nature in Chemistry of Heterocyclic Compounds
- Vol. 59 (6-7) , 1-8
Sulfo-Biginelli reaction: an insight into interaction between sulfamides and enolizable ketones
- 1 July 2023
- Published by Springer Nature in Chemistry of Heterocyclic Compounds
- Vol. 59 (6-7) , 429-441
Focused small molecule library of 5,6,7,8-tetrahydro[1,2,4]triazolo-[4,3-a]pyrazines: a brick for the house of medicinal chemistry
- 1 July 2023
- Published by Springer Nature in Chemistry of Heterocyclic Compounds
- Vol. 59 (6-7) , 429-441
Focused small molecule library of 5,6,7,8-tetrahydro[1,2,4]triazolo-[4,3-a]pyrazines: a brick for the house of medicinal chemistry
- Open Access
- 21 March 2023
- Published by International Union of Crystallography (IUCr) in Acta Crystallographica Section E Crystallographic Communications
- Vol. 79 (4) , 349-355
3,3′-(Phenylmethylene)bis(1-ethyl-3,4-dihydro-1H-2,1-benzothiazine-2,2,4-trione): single-crystal X-ray diffraction study, quantum-chemical calculations and Hirshfeld surface analysis
The title compound, C27H26N2O6S2, possesses potential antimicrobial, analgesic, and anti-inflammatory activity. This compound has three tautomeric forms, which relative energies were estimated with quantum-chemical calculations. All these tautomers (dienol form7A, keto–enol form7B, and diketo form7C) were optimized by the M06–2X/cc-pVTZ method in a vacuum, using the PCM model with chloroform and DMSO as solvent. The diketo form of the title compound proved to be the most energetically favourable as compared to the keto–enol or dienol forms. The diketo form can exist as three possible stereoisomers with the same configuration of one stereogenic center and different configurations of the stereogenic centers at two other atoms:(R,R,R),(S,R,S)and(R,R,S). The(R,R,S)stereoisomer was found in the crystal phase. It was revealed that the thiazine rings of equivalent benzothiazine fragments have different conformations, (a sofa or a half-chair). The two bicyclic fragments connected through the phenylmethylene group are oriented almost orthogonal to each other, subtending a dihedral angle of 82.16(7)°.
- 21 March 2023
- Published by International Union of Crystallography (IUCr) in Acta Crystallographica Section E Crystallographic Communications
- Vol. 79 (4) , 349-355
Open Access3,3′-(Phenylmethylene)bis(1-ethyl-3,4-dihydro-1H-2,1-benzothiazine-2,2,4-trione): single-crystal X-ray diffraction study, quantum-chemical calculations and Hirshfeld surface analysis
The title compound, C27H26N2O6S2, possesses potential antimicrobial, analgesic, and anti-inflammatory activity. This compound has three tautomeric forms, which relative energies were estimated with quantum-chemical calculations. All these tautomers (dienol form7A, keto–enol form7B, and diketo form7C) were optimized by the M06–2X/cc-pVTZ method in a vacuum, using the PCM model with chloroform and DMSO as solvent. The diketo form of the title compound proved to be the most energetically favourable as compared to the keto–enol or dienol forms. The diketo form can exist as three possible stereoisomers with the same configuration of one stereogenic center and different configurations of the stereogenic centers at two other atoms:(R,R,R),(S,R,S)and(R,R,S). The(R,R,S)stereoisomer was found in the crystal phase. It was revealed that the thiazine rings of equivalent benzothiazine fragments have different conformations, (a sofa or a half-chair). The two bicyclic fragments connected through the phenylmethylene group are oriented almost orthogonal to each other, subtending a dihedral angle of 82.16(7)°.
- Open Access
- 23 December 2022
- Published by National University of Pharmacy in Journal of Organic and Pharmaceutical Chemistry
- Vol. 20 (4) , 3-20
Multi-faceted Commercially Sourced Pd-Supported Reduction: A View from Practical Experience
Aim. To share our experience when working with the Pd-catalyzed hydrogenation and discuss reactions occurred contrary to our expectations, as well as express our vision of the causes for such an unusual reactivity.Results and discussion. Catalysis is a key technology and among the central themes of both petrochemical and fine chemical industries. Although extremely useful and reliable, it can sometimes astonish researchers. The paper discusses 17 intriguing cases of the catalytic hydrogenation and hydrogenolysis reactions from our practice in the High-pressure Synthesis Laboratory (Enamine Ltd.). All examples presented are characterized by peculiar performance of commercially sourced heterogeneous palladium-containing catalysts (Pd/C or Pd(OH)2). Thus, some cases were characterized by reduced activity of the catalyst (or even its complete loss), meaning that reaction conditions found before to be suitable for reduction appeared to be “broken”, and we had to search for a new, often harsher reaction setup. Curiously, it is a matter of classical Pd-catalyzed hydrogenations of N+–O– and C=C fragments. Apparently, these results indicate the heterogeneity of commercially available catalysts and are related to their fine internal structure, in particular the surface morphology. Another interesting issue the article deals with is chemoselectivity of the catalytic hydrogenation. Sometimes some reactions led to astonishing results going across theoretical views and expectations. Saturation of benzene rings instead of (or accompanying) debenzylation, breaking of the common order of hydrogenation for compounds containing several aromatic parts with different resonance energies, irreproducible experiment, obtaining of different products under the same conditions, uncommon results of Pd-catalyzed reactions is the list of interesting results, which we observed and discussed in the article. Analyzing the information available in the literature and considering all the results gathered we tend to believe that the presence of impurities of noble metals (Rh, Ru, Pt) in the catalysts used to be a possible reason for these strange findings. The study supports the general idea that commercial palladium catalysts differ in efficiency, resulting in significant differences in selectivity, reaction time, and yields. Elucidating the regularities behind such empirical results is undoubtedly an interesting area of research in the field of catalysis.Experimental part. All starting compounds exposed to hydrogenation were synthesized in Enamine Ltd. and had purity of not less than 95 %. The palladium-containing catalysts used in the experiment were purchased from 6 commercial sources within 2011 – 2022. The structure and purity of the compounds synthesized were characterized by 1H NMR spectroscopy, liquid chromatography coupled with the mass spectrometry method, elemental analysis. Chromatographic experiments revealed the purity of all compounds obtained being not less than 95 %.Conclusions. In the paper we have summarized our experience with the Pd-catalyzed hydrogenation and presented cases of unusual reactivity or unexpected outcomes of the reactions encountered in our practice. In general, complications we faced were of three types: (1) irreproducibility of the procedures most likely as the result of a changeable activity of the catalysts; (2) chemoselectivity issues when two or multireducible functional groups were present in the substrate; (3) undesirable Pd-catalyzed defunctionalization reactions. In turn, these complications led to increase in production costs, loss of time and resources. Therefore, because of this variability in the efficiency of Pd catalysts, far more efforts are required to find out the key differences between commercial sources of Pd catalysts, as well as to create protocols clearly defining the catalytic activity of each batch of the catalyst allowing to identify high-quality catalysts immediately prior to the use without wasting precious time and synthetic materials.
- 23 December 2022
- Published by National University of Pharmacy in Journal of Organic and Pharmaceutical Chemistry
- Vol. 20 (4) , 3-20
Open AccessMulti-faceted Commercially Sourced Pd-Supported Reduction: A View from Practical Experience
Aim. To share our experience when working with the Pd-catalyzed hydrogenation and discuss reactions occurred contrary to our expectations, as well as express our vision of the causes for such an unusual reactivity.Results and discussion. Catalysis is a key technology and among the central themes of both petrochemical and fine chemical industries. Although extremely useful and reliable, it can sometimes astonish researchers. The paper discusses 17 intriguing cases of the catalytic hydrogenation and hydrogenolysis reactions from our practice in the High-pressure Synthesis Laboratory (Enamine Ltd.). All examples presented are characterized by peculiar performance of commercially sourced heterogeneous palladium-containing catalysts (Pd/C or Pd(OH)2). Thus, some cases were characterized by reduced activity of the catalyst (or even its complete loss), meaning that reaction conditions found before to be suitable for reduction appeared to be “broken”, and we had to search for a new, often harsher reaction setup. Curiously, it is a matter of classical Pd-catalyzed hydrogenations of N+–O– and C=C fragments. Apparently, these results indicate the heterogeneity of commercially available catalysts and are related to their fine internal structure, in particular the surface morphology. Another interesting issue the article deals with is chemoselectivity of the catalytic hydrogenation. Sometimes some reactions led to astonishing results going across theoretical views and expectations. Saturation of benzene rings instead of (or accompanying) debenzylation, breaking of the common order of hydrogenation for compounds containing several aromatic parts with different resonance energies, irreproducible experiment, obtaining of different products under the same conditions, uncommon results of Pd-catalyzed reactions is the list of interesting results, which we observed and discussed in the article. Analyzing the information available in the literature and considering all the results gathered we tend to believe that the presence of impurities of noble metals (Rh, Ru, Pt) in the catalysts used to be a possible reason for these strange findings. The study supports the general idea that commercial palladium catalysts differ in efficiency, resulting in significant differences in selectivity, reaction time, and yields. Elucidating the regularities behind such empirical results is undoubtedly an interesting area of research in the field of catalysis.Experimental part. All starting compounds exposed to hydrogenation were synthesized in Enamine Ltd. and had purity of not less than 95 %. The palladium-containing catalysts used in the experiment were purchased from 6 commercial sources within 2011 – 2022. The structure and purity of the compounds synthesized were characterized by 1H NMR spectroscopy, liquid chromatography coupled with the mass spectrometry method, elemental analysis. Chromatographic experiments revealed the purity of all compounds obtained being not less than 95 %.Conclusions. In the paper we have summarized our experience with the Pd-catalyzed hydrogenation and presented cases of unusual reactivity or unexpected outcomes of the reactions encountered in our practice. In general, complications we faced were of three types: (1) irreproducibility of the procedures most likely as the result of a changeable activity of the catalysts; (2) chemoselectivity issues when two or multireducible functional groups were present in the substrate; (3) undesirable Pd-catalyzed defunctionalization reactions. In turn, these complications led to increase in production costs, loss of time and resources. Therefore, because of this variability in the efficiency of Pd catalysts, far more efforts are required to find out the key differences between commercial sources of Pd catalysts, as well as to create protocols clearly defining the catalytic activity of each batch of the catalyst allowing to identify high-quality catalysts immediately prior to the use without wasting precious time and synthetic materials.